ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO891

Association Between Coronary Artery Calcification Density and Serum Magnesium Levels in Maintenance Hemodialysis (MHD) Patients

Session Information

Category: Dialysis

  • 701 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Nishizawa, Yoshiko, Ichiyokai Harada Hospital, Hiroshima-shi, HIROSHIMA, Japan
  • Mizuiri, Sonoo, Ichiyokai Harada Hospital, Hiroshima-shi, HIROSHIMA, Japan
  • Ono, Kyoka, Ichiyokai Harada Hospital, Hiroshima-shi, HIROSHIMA, Japan
  • Yamashita, Kazuomi, Ichiyokai Harada Hospital, Hiroshima-shi, HIROSHIMA, Japan
  • Shigemoto, Kenichiro, Ichiyokai Harada Hospital, Hiroshima-shi, HIROSHIMA, Japan
  • Masaki, Takao, Division of Nephrology, Hiroshima, Japan
Background

Coronary artery calcification score (CACS) is determined by the plaque area and density. In general population, calcified plaques with lower density are associated with higher risk of incident cardiovascular events, but report on calcification density in hemodialysis patients was scanty. This study aimed to analyze the association between coronary artery calcification density (CACD) and clinical parameters in MHD patients.

Methods

Methods: The subjects were 289 Japanese MHD patients. Total calcified area (area), CACD, CACS, laboratory parameters, and medication use were studied at baseline. The subjects were stratified into CACD level tertiles (T1–T3) and assessed by Kruskal-Wallis test. Regression analyses for CACD and CACS were examined, respectively. Independent variables were age, sex, diabetes, CVD, serum magnesium, phosphate, uric acid, C-reactive protein (CRP), low-density lipoprotein cholesterol (LDL-C) levels and use of proton pump inhibitors (PPI) or sevelamer hydrochloride. Spearman’s correlations of the area and CACS or CACD were also analyzed, respectively.

Results

Among all patients, the mean age was 65±13 years, 37.2% were diabetics, and the median dialysis vintage was 72±99 months. The values of CACD of T1 (n=96), T2 (n=96), and T3 (n=97), were 3.61<, 3.62-3.89, and >3.90, respectively. The patients in T3 exhibited significantly higher serum magnesium, serum CRP and LDL-C levels (P<0.05). Multivariate regression analysis for CACD showed that age, diabetes, CVD [β 0.13, 95% confidence interval (CI) 0.00-0.12], and serum magnesium level [β 0.12, 95% CI (0.00-0.13)] were significantly related factors (P<0.05).While, multivariate regression analysis for CACS showed that age, diabetes, CVD [β 0.13, 95% CI 0.00-0.13], serum phosphate level [β 0.13, 95% CI (0.01-0.22)] were significantly related factors (P<0.05). CACS was correlated with total area (r = 013, P < 0.05), but the correlation between CACD and total area was not significant (r = 013, P=0.07 ).

Conclusion

CACD was significantly associated with serum magnesium levels, while CACS was significantly associated with serum phosphate levels in MHD patients. This may have a distinct clinical implication especially for coronary events.